Evidence map›Paper›PMID 27895578›Full record

ArticleFrontiers in aging neuroscience2016

Cognitive Performance Patterns in Healthy Individuals with Substantia Nigra Hyperechogenicity and Early Parkinson's Disease.

Rezzak Yilmaz, Susanne Gräber, Benjamin Roeben, Ulrike Suenkel, Anna-Katharina von Thaler, Sebastian Heinzel, Florian G Metzger, Gerhard W Eschweiler, Walter Maetzler, Daniela Berg and 1 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in aging neuroscience, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.

  1. Guideline
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Rezzak YilmazHertie Institute for Clinical Brain Research, Department of Neurodegeneration, University of Tuebingen Tuebingen, Germany.
Susanne GräberHertie Institute for Clinical Brain Research, Department of Neurodegeneration, University of TuebingenTuebingen, Germany; German Center for Neurodegenerative DiseasesTuebingen, Germany.
Benjamin RoebenHertie Institute for Clinical Brain Research, Department of Neurodegeneration, University of TuebingenTuebingen, Germany; German Center for Neurodegenerative DiseasesTuebingen, Germany.
Ulrike SuenkelHertie Institute for Clinical Brain Research, Department of Neurodegeneration, University of Tuebingen Tuebingen, Germany.
Anna-Katharina von ThalerHertie Institute for Clinical Brain Research, Department of Neurodegeneration, University of Tuebingen Tuebingen, Germany.
Sebastian HeinzelHertie Institute for Clinical Brain Research, Department of Neurodegeneration, University of TuebingenTuebingen, Germany; Department of Neurology, Christian-Albrechts-UniversityKiel, Germany.
Florian G MetzgerDepartment of Psychiatry and Psychotherapy, University of TuebingenTuebingen, Germany; Geriatric Center at the University Hospital of TuebingenTuebingen, Germany.
Gerhard W EschweilerDepartment of Psychiatry and Psychotherapy, University of TuebingenTuebingen, Germany; Geriatric Center at the University Hospital of TuebingenTuebingen, Germany.
Walter MaetzlerHertie Institute for Clinical Brain Research, Department of Neurodegeneration, University of TuebingenTuebingen, Germany; Department of Neurology, Christian-Albrechts-UniversityKiel, Germany; Geriatric Center at the University Hospital of TuebingenTuebingen, Germany.
Daniela BergHertie Institute for Clinical Brain Research, Department of Neurodegeneration, University of TuebingenTuebingen, Germany; Department of Neurology, Christian-Albrechts-UniversityKiel, Germany.
Inga Liepelt-ScarfoneHertie Institute for Clinical Brain Research, Department of Neurodegeneration, University of TuebingenTuebingen, Germany; German Center for Neurodegenerative DiseasesTuebingen, Germany.
Hertie Institute for Clinical Brain Research · DEKiel University · DEGerman Center for Neurodegenerative Diseases · DEUniversity of Tübingen · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

cognitionParkinson’s diseaseprodromal Parkinson’s diseasesubstantia nigra hyperechogenicitytranscranial sonography

Identifiers

PMID27895578
PMCPMC5108760
OpenAlexW2551718983

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.